Average Co-Inventor Count = 5.22
ph-index = 8
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Precision Biosciences, Inc. (18 from 48 patents)
18 patents:
1. 11788077 - Polynucleotides encoding optimized engineered meganucleases having specificity for a recognition sequence in the Hepatitis B virus genome
2. 11680254 - Engineered meganucleases specific for recognition sequences in the PCSK9 gene
3. 11278632 - Engineered nucleases useful for treatment of hemophilia A
4. 11268065 - Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene
5. 11266693 - Nucleic acids encoding engineered meganucleases with recognition sequences found in the human T cell receptor alpha constant region gene
6. 11142750 - Optimized engineered meganucleases having specificity for a recognition sequence in the Hepatitis B virus genome
7. 10799535 - Engineered meganucleases with recognition sequences found in the human T cell receptor alpha constant region gene
8. 10758595 - Treatment of retinitis pigmentosa using engineered meganucleases
9. 10603363 - Treatment of retinitis pigmentosa using engineered meganucleases
10. 10093899 - Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene
11. 10093900 - Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene
12. 9993501 - Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene
13. 9993502 - Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene
14. 9969975 - Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene
15. 9950010 - Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene